Description
| Product Name | CAT.No | Details |
| MSUD | BXC0811A | 50T |
Product Description
The Biorex Diagnostics Maple Syrup Urine Disease (MSUD) Test is a high-quality neonatal screening assay designed for the early detection of MSUD, a rare but potentially life-threatening inborn error of metabolism. Early diagnosis is critical, as timely dietary intervention can prevent severe neurological complications and other serious health outcomes. This assay provides a simple, reliable, and highly sensitive method for measuring the relevant branched-chain amino acids, making it ideal for clinical laboratories, hospitals, and large-scale newborn screening programmes.
Key Features
- Neonatal-Focused Sampling: Compatible with dried blood spots, plasma, or serum, allowing minimally invasive collection that is suitable for newborns.
- Accurate Quantification: Measures leucine, isoleucine, valine, and alloisoleucine precisely, providing reliable detection of elevated amino acid levels associated with MSUD.
- Rapid and Reliable Results: Delivers fast, reproducible measurements that support timely clinical decision-making and early dietary intervention.
- High Sensitivity and Specificity: Detects even mild elevations in amino acids, enabling early identification of affected infants.
- User-Friendly Workflow: Straightforward procedures and ready-to-use reagents allow efficient high-throughput neonatal screening.
- Laboratory Integration: Compatible with standard laboratory platforms and LIMS, ensuring seamless incorporation into existing workflows.
- Cost-Effective Solution: Designed for large-scale neonatal screening programmes, providing reliable testing at an economical price.
Benefits
The Biorex MSUD Test offers a trusted and clinically relevant solution for early detection of Maple Syrup Urine Disease. By providing accurate and reproducible measurements, this assay allows healthcare providers to implement timely dietary interventions, preventing severe metabolic crises and supporting improved long-term outcomes. Its ready-to-use format and scalable workflow make it ideal for routine hospital testing as well as population-wide newborn screening initiatives.
With its combination of precision, reliability, and operational efficiency, the Biorex MSUD Test ensures that at-risk infants are identified promptly, laboratories maintain consistent performance, and clinical teams can deliver optimal patient care.
Contact Us for more information.